Taldefgrobep alfa (USAN/INN);
Talditercept alfa (USAN)

C3386H5242N882O1048S16

75539.9538

75586.19

DKTHTCPPCP APELLGGPSV FLFPPKPKDT LMISRTPEVT CVVVDVSHED PEVKFNWYVD
GVEVHNAKTK PREEQYNSTY RVVSVLTVLH QDWLNGKEYK CKVSNKALPA PIEKTISKAK
GQPREPQVYT LPPSRDELTK NQVSLTCLVK GFYPSDIAVE WESNGQPENN YKTTPPVLDS
DGSFFLYSKL TVDKSRWQQG NVFSCSVMHE ALHNHYTQKS LSLSPELQLE ESAAEAQEGE
LEGVSDVPRD LEVVAATPTS LLISWTLPHA GRAHYYRITY GETGGNSPVQ EFTVPGRGVT
ATISGLKPGV DYTITVYAVT VTTTKVIHYK PISINYRTEI
(Disulfide bridge: 6-6', 9-9', 41-101, 41'-101', 147-205, 147'-205')

Myostatin inhibitor

Treatment of ALS, Duchenne muscular dystrophy and spinal muscular atrophy

MSTN [HSA:2660] [KO:K05497]